MarketPulse

Schedule III reclassification

4 articles
BenzingaBenzinga··Market News Updates

Medical Marijuana Market Eyes $130B Prize as Legalization Wave Fuels Global Expansion

Medical marijuana market projected to surge from $26-27B in 2026 to $130B+ by early-to-mid 2030s, driven by legalization, pharmaceutical innovation, and new product formats.
HITISchedule III reclassificationlegalization
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

From $300 to Pennies: Can Canopy Growth Survive Its Existential Crisis?

Canopy Growth stock has crashed 99% from $300 to under $2, posting weak financials and facing structural industry headwinds despite U.S. cannabis reclassification.
CGCstock declinefree cash flow
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Aurora Cannabis Faces Headwinds Despite Cannabis Reclassification

Aurora Cannabis stock down 96% since 2021. Despite cannabis reclassification benefits, the company faces headwinds from weak revenue, losses, and exited U.S. operations.
ACBacquisition strategystock performance
The Motley FoolThe Motley Fool··James Halley

Cannabis REIT IIPR Grapples With Revenue Decline and Unsustainable Dividend Amid Regulatory Hopes

Cannabis REIT IIPR faces revenue decline and unsustainable 111% dividend payout ratio, though potential federal cannabis reclassification and portfolio diversification could provide future upside.
IIPRIIPRpAdividend sustainabilityrevenue decline